MyAlcon | United Kingdom

This page is available in English. Select below for other countries.

MyAlcon | Country

This page is available in English. Select below for other countries.

MyAlcon Global Sites

Americas

     Canada - English / Français

     United States - English

 
Europe / Middle East / Africa
     United Kingdom - English

     Germany - Deutsch

     Switzerland - Deutsch

     Norway - Norwegian

     Sweden - Swedish

     Denmark - Danish

     Finland - Finnish

     Netherlands - Nederlands

 
Asia Pacific

     Australia - English

     India - English

     Japan - Japanese

 

COMING SOON

Americas
     Brazil
     Mexico
     Colombia
     Chile
     Argentina
     Ecuador
     Peru
     Uruguay
 
Europe / Middle East / Africa
     Spain
     Italy
     France

 

Asia Pacific
     South Korea
     China
     Hong Kong
     Singapore

Systane® COMPLETE

Relief for all types of dry eye

 

 

Key Benefits

Systane® COMPLETE is an all-in-one formula designed for ALL types of Dry Eye¹ (Mixed, Aqueous, & Lipid Deficient):

 

  • Works on all layers of the tear film¹.
  • Clinically proven to relieve all types of Dry Eye for up to 8 hours¹.

 

Systane COMPLETE pack shot

Features & Technology

 

  • A unique mechanism of action that optimises moisture & lipid delivery, thereby maintaining tear film integrity.²
  • Nano-droplet Technology enables an increased coverage of the ocular surface with the nano-sized lipid droplets and better stabilisation of lipid layer.³
  • Easy dosing due to the handy Drop-Tainer™ bottle.

 

Features and Technology

Patient Benefits

 

  • Ideal for patients with Mixed Dry Eye.
  • Also suitable for mild to moderate self-treating users*.
  • Can use before or after wearing contact lenses**.

 

 

 

Woman in hike gear standing in the field

References:

*Based on internal assessment and patient segmentation
**Please refere to instructions for use
***vs Systane® Balance

 

1. Silverstein S. et al. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial. Clinical Ophthalmology 2020:14 3167–3177
2. Alcon Data on file 2019.
3. Alcon Data on file 2019.